X2D-65841-68306
2 vaccinations
1 coded response
22 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 402 / KY
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2021-01-04
-
2021-01-11
Dose 2 — Pfizer-BioNTech
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Joint pains · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-12
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-13
- 2021-01-14
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-25
- 2021-02-01
-
2021-02-04
Call successfulDoes not wish to fill out VAERS report
- 2021-02-08
- 2021-02-10
- 2021-02-17
- 2021-04-13
-
2021-07-12
Survey response — 6 months, dose 2MedDRA: Hypertensive crisis, Postpartum disorder, Pre-eclampsia, Thrombocytopenia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Gestational thrombocytopeniaPostpartum preeclampsia with hypertensive crisis.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-12
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-13
- 2022-01-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-12 | Successful 2021-02-04 |
Does not wish to fill out VAERS report |
| 2021-07-12 | Unsuccessful |
Free text
Release 9 — 6 months, dose 2
Symptoms: Gestational thrombocytopeniaPostpartum preeclampsia with hypertensive crisis.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hypertensive crisis | ✓ | ✓ | ✓ |
| SD | Postpartum disorder | ✓ | ✓ | ✓ |
| SD | Pre-eclampsia | ✓ | ✓ | ✓ |
| SD | Thrombocytopenia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release